0001341235-13-000002.txt : 20130103 0001341235-13-000002.hdr.sgml : 20130103 20130103101305 ACCESSION NUMBER: 0001341235-13-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20130103 DATE AS OF CHANGE: 20130103 EFFECTIVENESS DATE: 20130103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aldexa Therapeutics, Inc. CENTRAL INDEX KEY: 0001341235 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-189330 FILM NUMBER: 13504512 BUSINESS ADDRESS: STREET 1: 15 NEW ENGLAND EXECUTIVE PARK CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 617-513-9882 MAIL ADDRESS: STREET 1: 15 NEW ENGLAND EXECUTIVE PARK CITY: BURLINGTON STATE: MA ZIP: 01803 FORMER COMPANY: FORMER CONFORMED NAME: Neuron Systems Inc DATE OF NAME CHANGE: 20051012 D 1 primary_doc.xml X0706 D LIVE 0001341235 Aldexa Therapeutics, Inc. 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA MASSACHUSETTS 01803 617-513-9882 DELAWARE Neuron Systems Inc Corporation true Todd Brady 15 New England Executive Park Burlington MA MASSACHUSETTS 01803 Executive Officer Director Gerald Cagle 15 New England Executive Park Burlington MA MASSACHUSETTS 01803 Executive Officer Director John Dowling 15 New England Executive Park Burlington MA MASSACHUSETTS 01803 Director Ben Bronstein 15 New England Executive Park Burlington MA MASSACHUSETTS 01803 Director Asish Xavier 15 New England Executive Park Burlington MA MASSACHUSETTS 01803 Director Gary Phillips 15 New England Executive Park Burlington MA MASSACHUSETTS 01803 Director Biotechnology Decline to Disclose 06 false 2012-12-20 false true true false 0 8787906 4793666 3994240 false 2 0 0 0 false Aldexa Therapeutics, Inc. Todd Brady Todd Brady President 2013-01-03